Ketamine Flashcards
Presentation
200 mg in 2 mL ampoule
Pharmacology
Rapid acting dissociative anaesthetic agent (primarily an NMDA receptor antagonist)
Pharmacology - Actions
Produces a dissociative state characterised by:
A trance-like state with eyes open but not responsive
Nystagmus
Profound analgesia
Normal pharyngeal and laryngeal reflexes
Normal or slightly enhanced skeletal muscle tone
Occasionally a transient and minimal respiratory depression
Metabolism
Metabolised = liver Excreted = kidneys
Indications
Rapid sequence intubation
Extreme traumatic pain refractory to opioid analgesia
Extreme agitation
CPR interfering patient
Contras
Known hypersensitivity Severe hypertension (SBP > 180)
Precautions
Any condition where significant elevation of BP would be hazardous. eg: Hypertension CVA Recent AMI CCF
For analgesia - inject slowly over 1 min to minimise risk of respiratory depression and hypertension
Route of administration
IV
IO
IM
Side effects - Cardiovascular
Increase in BP
Increase in HR
Side effects - CNS
Respiratory depression or apnoea
Emergence reactions (nightmares, restlessness, vivid dreams, confusion, hallucinations, irrational behaviour)
Enhanced skeletal tone
Nausea and vomiting
Side effects - Ocular
Diplopia and nystagmus with slight increase in intraocular pressure
Side effects - Other
Local pain at injection site
Lacrimation
Hypersalivation
Special notes
Emergence reactions, hallucinations or other behavioural disturbances associated with Ketamine administration for analgesia in adult patients may be managed with Midazolam (ALS consult only) 0.5-1 mg.
Consult with RCH to administer Midazolam in paediatric pts.
Hypersalivation may be managed with suctioning, or in severe cases IV or IM Atropine (MICA only)
IV effects
Onset = 30 secs Peak = N/A Duration = 10 mins
IM effects
Onset = 3-4 mins Peak = N/A Duration = 12-25 mins